| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CFO and Treasurer
2 companies
Krognes Steve E. is a Director at DNLI, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 42 sales. Those positions are worth an estimated $1.4M at current prices.
Our model assigns Krognes Steve E. a strong insider score of 74/100, based on 19 past trades. Over a 12-month horizon, 84.2% of those trades were profitable, with an average 12-month return of +27.1%.
Krognes Steve E.'s largest disclosed position is in GH as Director, worth about $1.4M. The recent filings there lean toward selling, a net 15,968 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,419 | $22.60 | $32,069.40 | -1.0% | -17.5% | +1.6% | |
| Feb 13, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 2,119 | $30.10 | $63,781.90 | -1.5% | +6.1% | -43.5% | |
| Feb 8, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,377 | $30.88 | $42,521.76 | -0.9% | -10.4% | -43.6% | |
| Jan 5, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 2,970 | $28.44 | $84,466.80 | -2.0% | -16.1% | -32.7% | |
| Aug 19, 2022 | DNLI Denali Therapeutics Inc. | Director | Sell | 2,253 | $33.22 | $74,844.66 | -1.5% | -12.6% | -31.9% | |
| Feb 11, 2022 | DNLI Denali Therapeutics Inc. | CFO and Treasurer | Sell | 2,560 | $34.69 | $88,806.40 | -2.1% | -37.4% | -16.4% | |
| Feb 9, 2022 | DNLI Denali Therapeutics Inc. | CFO and Treasurer | Sell | 1,296 | $37.09 | $48,072.66 | -1.0% | -40.1% | -21.7% | |
| Jan 5, 2022 | DNLI Denali Therapeutics Inc. | CFO and Treasurer | Sell | 2,225 | $44.75 | $99,568.75 | -1.8% | -25.3% | -35.5% | |
| Aug 19, 2021 | DNLI Denali Therapeutics Inc. | CFO and Treasurer | Sell | 2,285 | $49.57 | $113,263.20 | -2.3% | +1.5% | -31.6% | |
| Mar 15, 2021 | DNLI Denali Therapeutics Inc. | CFO and Treasurer | Sell | 50,000 | $61.89 | $3,094,563.14 | -5.6% | +21.0% | -52.2% |